European registry study on lymphatic treatments
Part of Blood & lymphatic, Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study is for people of any age with a confirmed central lymphatic disorder (a problem in the main lymphatic vessels, often linked to heart conditions or occurring on its own). Researchers want to collect information from different hospitals to learn more about these disorders and the best ways to treat them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed central lymphatic disorder, either on its own or with a heart condition.
- You must have had lymphatic imaging (like special scans) or tests to diagnose the problem.
- You must have had or are now having procedures to treat your lymphatic disorder, or are being watched without active treatment.
- You cannot have only a problem in the arm or leg lymph system that doesn’t affect the core area.
- You cannot have a short-term (<3-4 weeks) fluid leak after surgery that doesn't need treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have lymphatic anomalies (lymphatic birthmarks) and sometimes related vascular or genetic conditions. It aims to better understand how these problems develop and what genetic causes may be involved.
This trial looks at factors that affect study experiences for adults with lymphedema, including how they cope with scheduled visits and treatment during the study. It may help researchers improve how future lymphedema studies are run.
This study collects information from patients with lymphoproliferative disorders—conditions affecting blood and lymph cells—to help doctors better understand these diseases and improve care. Your medical records and information may be used to support research that could benefit future patients.
This study collects samples (like blood and possibly lymph fluid-related tests) to help doctors better tailor treatment for lymphedema. It may help researchers find ways to improve outcomes for people treated for swollen, fluid-rich tissue.
This study looks at lymphatic “drainage” problems (lymphedema) and how they develop after breast cancer treatment. It may help doctors better understand lymphedema and improve care for people who meet the study safety requirements.
This study tracks people newly diagnosed with non-Hodgkin lymphoma to learn more about the disease and how treatments work. It helps doctors improve future care by collecting real-world data.
Hear when a new Lymphatic Abnormalities trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.